1. Home
  2. VVOS vs IXHL Comparison

VVOS vs IXHL Comparison

Compare VVOS & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VVOS
  • IXHL
  • Stock Information
  • Founded
  • VVOS 2016
  • IXHL 2001
  • Country
  • VVOS United States
  • IXHL Australia
  • Employees
  • VVOS N/A
  • IXHL N/A
  • Industry
  • VVOS Medical Specialities
  • IXHL
  • Sector
  • VVOS Health Care
  • IXHL
  • Exchange
  • VVOS Nasdaq
  • IXHL Nasdaq
  • Market Cap
  • VVOS 17.5M
  • IXHL 20.5M
  • IPO Year
  • VVOS 2020
  • IXHL N/A
  • Fundamental
  • Price
  • VVOS $4.43
  • IXHL $0.21
  • Analyst Decision
  • VVOS Strong Buy
  • IXHL
  • Analyst Count
  • VVOS 2
  • IXHL 0
  • Target Price
  • VVOS $6.10
  • IXHL N/A
  • AVG Volume (30 Days)
  • VVOS 1.7M
  • IXHL 35.8M
  • Earning Date
  • VVOS 08-13-2025
  • IXHL 05-15-2025
  • Dividend Yield
  • VVOS N/A
  • IXHL N/A
  • EPS Growth
  • VVOS N/A
  • IXHL N/A
  • EPS
  • VVOS N/A
  • IXHL N/A
  • Revenue
  • VVOS $14,628,000.00
  • IXHL $98,000.00
  • Revenue This Year
  • VVOS $17.40
  • IXHL $3,817.06
  • Revenue Next Year
  • VVOS $10.78
  • IXHL $66.67
  • P/E Ratio
  • VVOS N/A
  • IXHL N/A
  • Revenue Growth
  • VVOS 9.47
  • IXHL N/A
  • 52 Week Low
  • VVOS $1.97
  • IXHL $0.08
  • 52 Week High
  • VVOS $6.28
  • IXHL $3.12
  • Technical
  • Relative Strength Index (RSI)
  • VVOS 80.66
  • IXHL 46.68
  • Support Level
  • VVOS $3.11
  • IXHL $0.20
  • Resistance Level
  • VVOS $4.68
  • IXHL $0.23
  • Average True Range (ATR)
  • VVOS 0.39
  • IXHL 0.01
  • MACD
  • VVOS 0.19
  • IXHL 0.01
  • Stochastic Oscillator
  • VVOS 90.57
  • IXHL 27.80

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: